Quarter Financials
Larimar Therapeutics, Inc. (LRMR)
$4.2
+0.11 (+2.69%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| Net Income | -8 | -5 | -8 | -8 | -9 | -9 | -9 | -17 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -166 | -158 | -152 | -142 | -134 | -125 | -116 | -107 |
|---|
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| Capital Expenditure | - | - | - | - | -0 | - | -0 | -0 |
|---|
| Net PPE | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 5 |
|---|
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| New Purchases | -6 | -0 | - | -35 | -26 | -72 | - | - |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|